Position Description

Associate Professor or Professor, CS, Phase I/Developmental Therapeutics Clinical Trials Program Head

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Phase I Developmental Therapeutics clinical trials program. The position will be dual appointed with a primary faculty appointment in the Clinical Research Division at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to the Senior Vice President (SVP) of the Clinical Research Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW.

We seek a visionary leader to head our Phase I Developmental Therapeutics Program, focusing on innovative therapies to provide hope and healing to cancer patients. This Program Head will lead and oversee the development and execution of early-phase clinical trials for novel cancer therapies. This role is crucial in translating groundbreaking research into clinical practice, ensuring the safe and efficient evaluation of new treatments. The successful candidate will partner with leaders of the Fred Hutch immunotherapy integrated research center and cell-based therapy team to develop and execute an institutional early phase trial strategy. The Program Head will foster strong collaborations with translational researchers and clinical investigators at UW and Fred Hutch and will forge partnerships with biotech and pharmaceutical industry partners to grow the phase I program assets and advance our mission of delivering transformative cancer therapies to our patients.

The Program Head's overall responsibility will be to maintain and expand our Phase 1 clinical trials program in collaboration with our immune therapy and cell-based therapy teams. Specific tasks will include (1) providing leadership in designing, implementing, and managing early-phase clinical trials; (2) working on a team to oversee appropriate selection and placement of phase I trials (3) coordinating the infrastructure needed for optimal implementation of phase I studies, including research nurses, data coordinators, regulatory affairs, tissue acquisition, and biostatistical support; (4) working with medical oncology and other faculty to assure patient accrual to studies; (5) direct care of a portion of the study patients in addition to the faculty member's standard of care patients; and (6) outreach to community oncology providers to enhance access to Phase 1 trials. The candidate may also specialize in the treatment of a cancer subtype, in which case they could maintain a subspecialty clinic that is separate from their role as the Phase I Program Head. The incumbent will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts for an established team of clinical researchers involved in conducting phase I trials. Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty leading Phase I trials. Teaching responsibilities will involve oversight of advanced practice providers and fellows during inpatient and outpatient rotations, and delivery of informal teaching sessions and formal lectures to providers and the general medical community.

Appointment at Fred Hutch would be at the rank of associate or full professor in the Clinical Research Division of the Fred Hutch. Appointment to the full-time faculty at the UW would be at the rank of associate or full professor, without tenure due to funding. Academic appointments at the University of Washington will be commensurate with experience, qualifications, and academic rank. Associate and full professors hold indefinite appointments that both align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

Opportunities exist for joint and/or affiliate appointment in the Fred Hutch Divisions of Public Health Sciences, Translational Science and Therapeutics, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, depending on mutual interests. Fred Hutch and University of Washington faculty engage in teaching, research, and service.

The successful candidate will be appointed in the Clinician Scholar track and will spend approximately 30% of time on clinical care based on the candidate's interests (and institutional need). The remainder of the incumbent's time will be protected for research, administrative oversight of the Fred Hutch Phase I clinical research programs, teaching and mentorship, for the first three years, after which, the incumbent would be expected to cover at least half of their salary each year through grants, contracts, or clinical work.

Strong candidates will demonstrate evidence of both leadership of Phase I research and clinical excellence.

Fred Hutch is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world's leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world's deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

This position is paid directly by Fred Hutchinson Cancer Center (Fred Hutch) and receives no UW compensation. Please refer to Fred Hutch for information about compensation for this position.

Anticipated Start Date: March 1, 2025

Qualifications

Applicants must have:

* MD/DO degree (or foreign equivalent)

* Board certification in medical oncology (or foreign equivalent)

* Eligibility for medical licensure in the state of Washington.

In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) or equivalent as determined by the Secretary of Health and Human Services.

The ideal candidate will have a record of and primary interest in Phase I research, as demonstrated by peer-reviewed publications, grants and/or clinical trial experience.

Instructions

Interested candidates should submit the following:

1) Letter of interest addressed to the Chair of the Phase I Clinical Trials Program Head Search Advisory Committee, Dr. Gabi Chiorean

2) Curriculum vitae

3) One-page personal statement discussing research accomplishments, leadership experience, and outlining a vision for the growth and development of the Phase I program

4) Diversity, equity, and inclusion statement describing past contributions to diversity, equity, and inclusion and future plans for continuing these efforts (two pages or less)

5) List of five (5) references (References will not be contacted without first discussing this with the applicant).

Equal Employment Opportunity Statement

University of Washington is an affirmative action and equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, sex, sexual orientation, marital status, pregnancy, genetic information, gender identity or expression, age, disability, or protected veteran status.

Benefits Information

A summary of benefits associated with this title/rank can be found at https://hr.uw.edu/benefits/benefits-orientation/benefit-summary-pdfs/. Appointees solely employed and paid directly by a non-UW entity are not UW employees and are not eligible for UW or Washington State employee benefits.

Commitment to Diversity

The University of Washington is committed to building diversity among its faculty, librarian, staff, and student communities, and articulates that commitment in the UW Diversity Blueprint (http://www.washington.edu/diversity/diversity-blueprint/). Additionally, the University's Faculty Code recognizes faculty efforts in research, teaching and/or service that address diversity and equal opportunity as important contributions to a faculty member's academic profile and responsibilities (https://www.washington.edu/admin/rules/policies/FCG/FCCH24.html#2432).

Privacy Notice

Review the University of Washington Privacy Notice for Demographic Data of Job Applicants and University Personnel to learn how your demographic data are protected, when the data may be used, and your rights.

Disability Services

To request disability accommodation in the application process, contact the Disability Services Office at 206-543-6450 or dso@uw.edu.